Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage
Open Access
- 5 June 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (23), 15564-15572
- https://doi.org/10.1074/jbc.m806584200
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Novel anti-inflammatory mechanisms ofN-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damageAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In VivoHypertension, 2008
- NADPH Oxidase Contributes to Vascular Inflammation, Insulin Resistance, and Remodeling in the Transgenic (mRen2) RatHypertension, 2007
- Decreased Endogenous Levels of Ac-SDKP Promote Organ FibrosisHypertension, 2007
- Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 ratAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Role of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline in the Antifibrotic and Anti-Inflammatory Effects of the Angiotensin-Converting Enzyme Inhibitor Captopril in HypertensionHypertension, 2007
- Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertensionAmerican Journal of Physiology-Renal Physiology, 2005
- Malignant hypertension - the role of the paracrine renin-angiotensin systemThe Journal of Pathology, 2000
- Spontaneous development of malignant phase hypertension in transgenic Ren-2 ratsKidney International, 1994
- An improved fluorometric assay of rat serum and plasma converting enzyme.Hypertension, 1985